Manulife (Manufacturers Life Insurance)
APGE icon

Manulife (Manufacturers Life Insurance)’s Apogee Therapeutics APGE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.78M Sell
68,696
-12,136
-15% -$881K 0.01% 1093
2025
Q4 		$6.12M Buy
80,832
+17,607
+28% +$1.11M 0.01% 1094
2025
Q3 		$2.51M Sell
63,225
-9,714
-13% -$371K ﹤0.01% 1432
2025
Q2 		$3.17M Sell
72,939
-14,408
-16% -$548K ﹤0.01% 1337
2025
Q1 		$3.26M Sell
87,347
-606
-0.7% -$23.4K ﹤0.01% 1321
2024
Q4 		$3.98M Buy
87,953
+19,965
+29% +$1.02M ﹤0.01% 1289
2024
Q3 		$3.99M Sell
67,988
-3,655
-5% -$175K ﹤0.01% 1303
2024
Q2 		$2.82M Sell
71,643
-13,558
-16% -$658K ﹤0.01% 1385
2024
Q1 		$5.66M Buy
85,201
+34,101
+67% +$1.49M 0.01% 1137
2023
Q4 		$1.43M Buy
51,100
+1,745
+4% +$35K ﹤0.01% 1629
2023
Q3 		$1.05M Buy
+49,355
New +$1.09M ﹤0.01% 1705

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s APGE Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Apogee Therapeutics (APGE) stake by 15% in Q1 2026, selling an estimated $881K and leaving 68,696 shares worth $5.78M. The position accounts for 0.01% of the portfolio, ranked #1093.

Manulife (Manufacturers Life Insurance) first reported a position in APGE in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.12M in Q4 2025. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 68,696 shares of Apogee Therapeutics worth $5.78M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 12,136 Apogee Therapeutics shares in Q1 2026, an estimated $881K.
  • Apogee Therapeutics made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1093 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Apogee Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Apogee Therapeutics position peaked at $6.12M in Q4 2025.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.